No abstract

No abstract

No abstract

What is already known?  The use of pharmaceutical products to manage GOR has increased in some countries  Evidence supporting the use of medicines in the management of GOR are equivocal  Ranitidine and omeprazole are not yet licensed for use in infants under 1 year old age. What this study adds?  There is an increasing use of alginate (Gaviscon), ranitidine (H2RA) and omeprazole (PPI) in the management of symptoms of GOR/ GORD in Scotland.